000			03855namaa2200625uu 4500
001			oapen33055
003			oapen
005			20251217011900.0
006			a||||fo|||||||||0|
007			cr|mn|---annan
008			240424s2013a||||fo|||||||||0|eng d
014			_a842881514 _bOCoLC
020			_a9780199659210
024	7		_a10.1093/acprof:oso/9780199659210.001.0001 _2doi
035			_a(OCoLC)842881514
040			_aoapen _coapen
041	0		_aeng
042			_adc
072		7	_aL _2thema
072		7	_aLN _2thema
072		7	_aLNT _2thema
072		7	_aLNTM _2thema
100	1		_aFarrell, Anne-Maree _4aut
245	1	0	_aEuropean Law and New Health Technologies
260			_aOxford (UK) _bOxford University Press _c2013
300			_a1 online resource (480 p.)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
490	1		_aOxford Studies in European Law
506	0		_aFree-to-read _fUnrestricted online access _2star
520			_aHealth is a matter of fundamental importance in European societies, both as a human right in itself, and as a factor in a productive workforce and therefore a healthy economy. New health technologies promise improved quality of life for patients suffering from a range of diseases, and the potential for the prevention of incidence of disease in the future. At the same time, new health technologies pose significant challenges for governments, particularly in relation to ensuring the technologies are safe, effective, and provide appropriate value for (public) money. To guard against the possible dangers arising from new health technologies, and to maximize the benefits, all European governments regulate their development, marketing, and public financing. In addition, several international institutions operating at European level, in particular the European Union, the Council of Europe, and the European Patent Office, have become involved in the regulation of new health technologies. They have done so both through traditional 'command and control' legal measures, and through other regulatory mechanisms, including guidelines, soft law, 'steering' through redistribution of resources, and private or quasi-private regulation. This collection analyses European law and its relationships with new health technologies. It uses interdisciplinary insights, particularly from law but also drawing on regulation theory, and science and technology studies, to shed new light on some of the key defining features of the relationships and especially the roles of risk, rights, ethics, and markets. The collection explores the way in which European law's engagement with new health technologies is to be legitimized, and discusses the implications for biological or biomedical citizenship.
540			_aOpen licence _0https://oapen.org/article/rights
546			_aeng
650		0	_aMedical technology _xLaw and legislation _zEuropean Union countries.
650		7	_aLaw. _2bicssc
650		7	_aLaw _2thema
650		7	_aLaws of specific jurisdictions and specific areas of law _2thema
650		7	_aLaws of Specific jurisdictions. _2bicssc
650		7	_aMedical and healthcare law. _2bicssc
650		7	_aMedical and healthcare law _2thema
650		7	_aMedical technology _xLaw and legislation _2fast
650		7	_aSocial law and Medical law _2thema
650		7	_aSocial law. _2bicssc
653			_aeuropean law
653			_ahealth
653			_ahealth technologies
653			_aregulation theory
700	1		_aFarrell, Anne-Maree _4edt
700	1		_aFlear, Mark L _4edt
700	1		_aHervey, Tamara K _4edt
700	1		_aMurphy, Thérèse _4edt
793	0		_aOAPEN Library.
856	4	0	_uhttps://library.oapen.org/handle/20.500.12657/33055 _zFree-to-read: OAPEN Library/DOAB: description of the publication _70
999			_c37705 _d37705